French bill's approval means more sales taxes and price cuts for pharma in 2012
This article was originally published in SRA
Executive Summary
A higher levy on pharmaceutical sales, more price cuts and greater use of medico-economic assessments are all in store next year after the lower house of the French parliament finally adopted the social security financing bill for 20121.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.